Helping EGFR inhibition to block cancer
Nature Neuroscience 20, 1035 (2017).
doi:10.1038/nn.4605
Authors: Rolf Warta & Christel Herold-Mende
Effectiveness of EGFR treatment is impaired through an early adaptive response. TNF–JNK–Axl–ERK signaling contributes to this primary resistance to EGFR inhibition and might serve as novel target to improve EGFR inhibition.
Source: Nature Neuroscience - Category: Neuroscience Authors: Rolf Warta Christel Herold-Mende Tags: News and Views Source Type: research